Category Business

Sanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS

Sanofi Showcases Expansive Respiratory Innovation and Scientific Leadership at ATS 2025 with Robust Clinical Data from Dupixent and Immunology Pipeline Sanofi is poised to make a major impact at the 2025 American Thoracic Society (ATS) International Conference, taking place from…

Read MoreSanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS
, PCI Pharma

PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity

PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in the development and commercialization of innovative biopharmaceutical therapies, has officially…

Read MorePCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity
Sunflower Therapeutics

Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group

Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group Sunflower Therapeutics, a public benefit corporation with a mission to transform global access to protein manufacturing capacity, has taken a significant step toward commercial expansion with the announcement of a new…

Read MoreSunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group
Ray Therapeutics

Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease

Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease In a significant milestone for the field of regenerative medicine and vision restoration, Ray Therapeutics—a clinical-stage biotechnology company specializing in optogenetic gene therapies—has been awarded…

Read MoreRay Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease
Kashiv BioSciences

Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management

Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful execution of a senior secured credit agreement with GoldenTree Asset…

Read MoreKashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management